Literature DB >> 10405207

Thrombin stimulates synthesis of type IV collagen and tissue inhibitor of metalloproteinases-1 by cultured human mesangial cells.

M Kaizuka1, H Yamabe, H Osawa, K Okumura, N Fujimoto.   

Abstract

Glomerular accumulation of extracellular matrix (ECM) is the common pathologic feature following glomerular injury, and the alteration in the synthesis and degradation of ECM may be involved in the glomerular accumulation of ECM. Glomerular fibrin formation occurs in various forms of human and experimental glomerulonephritis, and it may play an important role in progressive glomerular injury. Thrombin, a multifunctional serine proteinase that is generated at the site of vascular injury, has central functions in hemostasis and it also shows various biologic effects. In this study, it is hypothesized that thrombin may alter the production and the degradation of type IV collagen, which is an important component of ECM in the glomeruli. Human mesangial cells (HMC) were cultured, and the levels of type IV collagen, tissue inhibitor of metalloproteinase-1 (TIMP-1), and matrix metalloproteinase-2 (MMP-2) in the culture supernatants were measured by enzyme immunoassay using specific antibodies. MMP-2 activity was also evaluated by zymography using polyacrylamide/ sodium dodecyl sulfate gel-containing gelatin. Thrombin increased the production of type IV collagen and TIMP-1 in a dose-and time-dependent manner, but it did not increase MMP-2. Thrombin also stimulated the gene expressions of the type IV collagen and TIMP-1 in HMC in a dose- and time-dependent manner. Thrombin treated with diisopropylfluorophosphate, a serine proteinase inhibitor, did not show any of these effects. Hirudin, a natural thrombin inhibitor, and anti-transforming growth factor-beta-neutralizing antibody inhibited the stimulating effect of thrombin. These findings suggest that thrombin may contribute to the excessive accumulation of ECM and progression of glomerulosclerosis through an increase of type IV collagen production and a decreased matrix degradation presumably via a transforming growth factor-beta-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405207     DOI: 10.1681/ASN.V1071516

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

1.  Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1.

Authors:  Jong-Sup Bae; In-San Kim; Alireza R Rezaie
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Dabigatran abrogates brain endothelial cell permeability in response to thrombin.

Authors:  Brian Thomas Hawkins; Yu-Huan Gu; Yoshikane Izawa; Gregory John del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

3.  Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining.

Authors:  Tetsuya Endo; Kimimasa Nakabayashi; Makiho Sekiuchi; Tadahide Kuroda; Akinori Soejima; Akira Yamada
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

4.  Microarray analysis of prothrombin knockdown in zebrafish.

Authors:  Kenneth R Day; Pudur Jagadeeswaran
Journal:  Blood Cells Mol Dis       Date:  2009-05-13       Impact factor: 3.039

5.  A role for thrombin in liver fibrosis.

Authors:  J Gillibert Duplantier; L Dubuisson; N Senant; G Freyburger; I Laurendeau; J-M Herbert; A Desmoulière; J Rosenbaum
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

6.  Thrombin promotes fibronectin secretion by bone marrow mesenchymal stem cells via the protease-activated receptor mediated signalling pathways.

Authors:  Jin Chen; Yujie Ma; Zi Wang; Hengxiang Wang; Lisheng Wang; Fengjun Xiao; Hua Wang; Jianming Tan; Zikuan Guo
Journal:  Stem Cell Res Ther       Date:  2014-03-17       Impact factor: 6.832

Review 7.  Innate immunity in diabetic kidney disease.

Authors:  Sydney C W Tang; Wai Han Yiu
Journal:  Nat Rev Nephrol       Date:  2020-01-15       Impact factor: 28.314

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.